{"id":96928,"date":"2023-06-12T06:51:02","date_gmt":"2023-06-12T06:51:02","guid":{"rendered":"https:\/\/haberulus.net\/?p=96928"},"modified":"2023-06-12T06:51:02","modified_gmt":"2023-06-12T06:51:02","slug":"biontechin-covid-19-asisina-dava-simdi-de-parayi-kim-odeyecek-tartismasi-cikti","status":"publish","type":"post","link":"https:\/\/haberulus.net\/?p=96928","title":{"rendered":"BioNTech\u2019in Covid-19 a\u015f\u0131s\u0131na dava: \u015eimdi de paray\u0131 kim \u00f6deyecek tart\u0131\u015fmas\u0131 \u00e7\u0131kt\u0131"},"content":{"rendered":"

2019\u2019un son haftalar\u0131nda \u00c7in\u2019in Wuhan kentinde ortaya \u00e7\u0131kan ve k\u0131sa bir s\u00fcre i\u00e7inde k\u00fcresel bir salg\u0131n halini alan corona vir\u00fcs\u00fcne kar\u015f\u0131 mRNA bazl\u0131 a\u015f\u0131 geli\u015ftirerek bunu Pfizer ile satan BioNTech\u2019e y\u00f6nelik \u015fikayet ve tazminat davas\u0131n\u0131n ilk duru\u015fmas\u0131 bug\u00fcn ger\u00e7ekle\u015fecek.<\/p>\n

Almanya\u2019da ismini a\u00e7\u0131klamayan orta ya\u015fl\u0131 bir kad\u0131n\u0131n a\u00e7t\u0131\u011f\u0131 davada, T\u00fcrkiye\u2019de de kullan\u0131lan Comirnaty isimli a\u015f\u0131n\u0131n yan etkilere sebebiyet verdi\u011fi iddia edilirken kad\u0131n\u0131n \u201cen az\u201d 150 bin euro (yakla\u015f\u0131k 3.7 milyon TL) talep etti\u011fi kaydedildi.<\/p>\n

\"\"<\/p>\n

T\u00fcrk bilim insanlar\u0131 \u00d6zlem T\u00fcreci ve U\u011fur \u015eahin\u2019in kurdu\u011fu BioNTech, a\u015f\u0131lar\u0131n g\u00fcvenli oldu\u011funu a\u00e7\u0131klad\u0131.<\/p>\n<\/div>\n

Hamburg\u2019da g\u00f6r\u00fclecek davada kad\u0131n\u0131 Rogert & Ulbrich isimli hukuk \u015firketi temsil edecek. Kad\u0131n, a\u015f\u0131 olduktan sonra uyku sorunu ya\u015fad\u0131\u011f\u0131, halsizlik ve bedeninin \u00fcst\u00fcnde a\u011fr\u0131 hissetti\u011fini s\u00f6ylerken yutkunma zorlu\u011fu ya\u015fad\u0131\u011f\u0131n\u0131n da alt\u0131n\u0131 \u00e7izdi.<\/p>\n

Rogert & Ulbrich\u2019in ortaklar\u0131ndan Tobias Ulbrich, \u0130ngiliz haber ajans\u0131 Reuters\u2019a konu\u015ftu. Ulbrich, Avrupa Birli\u011fi yasalar\u0131 ve Alman denetleyici kurumlar\u0131 hedef ald\u0131klar\u0131n\u0131 s\u00f6yledi.<\/p>\n

EMA: A\u015eILAR EN AZ 20 M\u0130LYON \u0130NSANI KURTARDI<\/strong><\/p>\n

Almanya\u2019da ila\u00e7 yasalar\u0131na g\u00f6re a\u015f\u0131 ve ila\u00e7 \u00fcreticileri bilimsel olarak \u00fcr\u00fcnlerinin yan etkilerinin kan\u0131tlanmas\u0131 durumunda para cezas\u0131 alabiliyor. BioNTech, a\u015f\u0131n\u0131n g\u00fcvenli oldu\u011funu duyururken, Avrupa \u0130la\u00e7 Dairesi (EMA) taraf\u0131ndan yap\u0131lan a\u00e7\u0131klamada da BioNTech\u2019in geli\u015ftirdi\u011fi Comirnaty isimli a\u015f\u0131n\u0131n g\u00fcvenli oldu\u011funa vurgu yap\u0131ld\u0131.<\/p>\n

EMA, BioNTech\u2019in geli\u015ftirdi\u011fi a\u015f\u0131lar\u0131n d\u00fcnya \u00e7ap\u0131nda en az 20 milyon insan\u0131n hayat\u0131n\u0131 kurtard\u0131\u011f\u0131n\u0131 belirtti. BioNTech\u2019in a\u015f\u0131s\u0131nda \u00e7ok az bir risk oldu\u011fu belirtilirken, \u201cbeklenmeyen yan etki\u201dnin \u00e7ok nadiren g\u00f6r\u00fcld\u00fc\u011f\u00fc de aktar\u0131ld\u0131. En s\u0131k g\u00f6r\u00fclen yan etkiler aras\u0131nda ba\u015f a\u011fr\u0131s\u0131, y\u00fcksek ate\u015f, halsizlik ve kas a\u011fr\u0131s\u0131 oldu\u011fu da belirtildi.<\/p>\n

\u00d6DEMEY\u0130 K\u0130M YAPACAK?<\/strong><\/p>\n

\u0130ngiliz haber ajans\u0131 Reuters\u2019\u0131n haberinde, BioNTech\u2019in davay\u0131 kaybetmesi durumunda \u00f6demeyi kimin yapaca\u011f\u0131n\u0131n net olmad\u0131\u011f\u0131 da belirtildi.<\/p>\n

Reuters\u2019a konu\u015fan baz\u0131 kaynaklar, \u201cAvrupa Birli\u011fi ile yap\u0131lan toplu anla\u015fmalarda, BioNTech ve Pfizer\u2019\u0131n olas\u0131 bir yasal masraftan ve potansiyel tazminattan tamamen ya da k\u0131smen feragat etme hakk\u0131 bulunuyor. Bu durum da AB h\u00fck\u00fcmetlerini bu tazminat\u0131 \u00f6demeye zorlayabilir\u201d dedi.<\/p>\n

Almanya\u2019da a\u015f\u0131lardan kal\u0131c\u0131 hasar alan bireyleri koruyan bir sistem bulunurken, ABD\u2019de Covid-19 a\u015f\u0131s\u0131 \u00fcreticileri olas\u0131 bir yasal s\u00fcre\u00e7te dokunulmazl\u0131k alm\u0131\u015ft\u0131.<\/p>\n

Bug\u00fcn g\u00f6r\u00fclecek davada taraf olan Rogert & Ulbrich isimli hukuk \u015firketi yakla\u015f\u0131k 250 ki\u015fi ad\u0131na dava a\u00e7\u0131laca\u011f\u0131n\u0131 belirtirken, Caesar-Preller isimli \u015firket ise 100 davaya bakacaklar\u0131n\u0131 duyurdu. Almanya\u2019n\u0131n yan\u0131 s\u0131ra \u0130talya\u2019da da benzer davalar a\u00e7\u0131ld\u0131\u011f\u0131 kaydedildi.<\/p>\n

HUKUK \u015e\u0130RKETLER\u0130 TARTI\u015eMA YARATTI<\/strong><\/p>\n

Rogert & Ulbrich ve Casar-Preller isimli hukuk \u015firketleri, maddi kazan\u00e7 elde etmek i\u00e7in insanlar\u0131n endi\u015felerini s\u00f6m\u00fcrd\u00fcklerine y\u00f6nelik iddialar\u0131 ise yalanlad\u0131.<\/p>\n

\u0130ngiliz Financial Times gazetesi, \u015firketlerden birinin D\u00fcsseldorf merkezli Rogert & Ulbrich oldu\u011funu ve di\u011fer \u015firketin ise Mainz merkezli Casar-Preller oldu\u011funu duyurmu\u015ftu. Her iki \u015firket de ge\u00e7mi\u015fte Alman otomotiv markas\u0131 Volkswagen’in diesel yak\u0131t skandal\u0131ndan hukuki zafer kazanm\u0131\u015f fakat Alman medyas\u0131 bu iki \u015firketi \u015f\u00f6hret ve para elde etmek i\u00e7in s\u00f6m\u00fcrmekle su\u00e7lam\u0131\u015ft\u0131.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

D\u00fcnya \u00e7ap\u0131nda 6 milyondan fazla insan\u0131n \u00f6l\u00fcm\u00fcne sebep olan corona vir\u00fcs\u00fc salg\u0131n\u0131na kar\u015f\u0131 Pfizer\/BioNTech’in geli\u015ftirdi\u011fi mRNA bazl\u0131 a\u015f\u0131n\u0131n “yan etkileri” sebebiyle dava a\u00e7an Alman kad\u0131n\u0131n davas\u0131n\u0131n ilk duru\u015fmas\u0131 bug\u00fcn g\u00f6r\u00fclecek. Kaynaklar, duru\u015fma \u00f6ncesinde baz\u0131 a\u00e7\u0131klamalarda bulundu.<\/p>\n","protected":false},"author":1,"featured_media":96929,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[688,180,2043,775,217],"class_list":["post-96928","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-alman","tag-asi","tag-biontech","tag-dava","tag-sirket"],"_links":{"self":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/96928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=96928"}],"version-history":[{"count":1,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/96928\/revisions"}],"predecessor-version":[{"id":96930,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/96928\/revisions\/96930"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/media\/96929"}],"wp:attachment":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=96928"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=96928"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=96928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}